Sweet GRAS for “Bitter blocker”
This article was originally published in The Tan Sheet
Executive Summary
FDA affirms adenosine monophosphate (AMP) - a natural compound that can be used to block the bitter taste of oral pharmaceuticals - as generally recognized as safe, Linguagen announces Sept. 15. AMP can "improve the taste" of products "without adding excess salt or sugar" and can be used in foods and beverages, Linguagen notes. The Cranbury, N.J.-based firm received a two-year, $746,000 NIH grant in 2002 to conduct research on AMP's ability to block the bitter taste signal pathway caused by pharmaceutical agents (1"The Tan Sheet" Oct. 7, 2002, p. 12)...
You may also be interested in...
OTC Drug Bitter Taste-Blocking Compound Receives $746,000 NIH Grant
NIH-funded research evaluating the efficacy of a bitter taste-inhibiting compound could result in the development of "more palatable" oral OTC drugs and subsequent improvements in patient compliance, according to grantee Linguagen Corp
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.